Skip to main content
Clinical Trials/ACTRN12621000627853
ACTRN12621000627853
Not yet recruiting
未知

Investigating the association between endometrial cystic spaces, endometrial hyperplasia and endometrial cancer in women with abnormal bleeding

The Royal Women's Hospital0 sites792 target enrollmentMay 25, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Endometrial cysts
Sponsor
The Royal Women's Hospital
Enrollment
792
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 25, 2021
End Date
TBD
Last Updated
4 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
The Royal Women's Hospital

Eligibility Criteria

Inclusion Criteria

  • Women aged 30 years old and above
  • With abnormal uterine bleeding
  • o Defined by any of the following: Postmenopausal bleeding
  • Intermenstrual bleeding
  • Postcoital bleeding with a normal cervical screening test (CST) Bleeding less than every 22 days
  • Heavy or prolonged bleeding
  • And waitlisted for HDC or endometrial biopsy for investigation of abnormal uterine bleeding

Exclusion Criteria

  • Inability to consent: no capacity or does not fully comprehend consent information
  • Known current or previous history of endometrial hyperplasia or endometrial cancer
  • Endometrial sampling or intrauterine manipulation performed less than 28 days prior to
  • recruitment (due to potential alteration of endometrium and impact on subsequent ultrasound
  • Non english speaking background

Outcomes

Primary Outcomes

Not specified

Similar Trials